Market Tracker

02/12 5:16pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.2231
Delayed Data
As of Feb 12
 +0.0087 / +4.06%
Today’s Change
0.20
Today|||52-Week Range
0.65
-37.21%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.21
Today’s open0.21
Day’s range0.21 - 0.23
Volume70,770
Average volume (3 months)396,233
Market cap$20.1M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.61

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...-0.02-2.76%
OPGNOpGen Inc0.000.00%
HTGMHTG Molecular Diagno...-0.13-5.05%
AEZSAEterna Zentaris Inc+0.04+1.40%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Chief Accounting Officer &
Vice President-Finance
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts